Page 188 - IJB-10-2

International Journal of Bioprinting Coronavirus-infected bioprinted intestine

in a microengineered gut-on-a-chip. iScience. 2019;15: dimensional printing. Nat Mater. 2017;16(3):303-308.
391-406. doi: 10.1038/nmat4782
doi: 10.1016/j.isci.2019.04.037
92. Trampe E, Koren K, Akkineni AR, et al. Functionalized
80. Jalili-Firoozinezhad S, Gazzaniga FS, Calamari EL, et al. A bioink with optical sensor nanoparticles for O2
complex human gut microbiome cultured in an anaerobic imaging in 3D-bioprinted constructs. Adv Funct Mater.
intestine-on-a-chip. Nat Biomed Eng. 2019;3(7):520-531. 2018;28(45):1804411.
doi: 10.1038/s41551-019-0397-0 doi: 10.1002/adfm.201804411
81. Madden LR, Nguyen TV, Garcia-Mojica S, et al. Bioprinted 93. Vancamelbeke M, Vermeire S. The intestinal barrier:
3D primary human intestinal tissues model aspects of native a fundamental role in health and disease. Expert Rev
physiology and ADME/Tox functions. iScience. 2018;2: Gastroenterol Hepatol. 2017;11(9):821-834.
156-167. doi: 10.1080/17474124.2017.1343143
doi: 10.1016/j.isci.2018.03.015
94. Lee Y, Kim M-H, Alves DR, et al. Gut–kidney axis on chip
82. Torras N, Zabalo J, Abril E, Carré A, García-Díaz M, Martínez for studying effects of antibiotics on risk of hemolytic uremic
E. A bioprinted 3D gut model with crypt-villus structures to syndrome by shiga toxin-producing escherichia coli. Toxins.
mimic the intestinal epithelial-stromal microenvironment. 2021;13(11):775.
Biomater Adv. 2023;153:213534. doi: 10.3390/toxins13110775
doi: 10.1016/j.bioadv.2023.213534
95. Skardal A, Murphy SV, Devarasetty M, et al. Multi-tissue
83. Han H, Park Y, Choi Y-M, et al. A bioprinted tubular interactions in an integrated three-tissue organ-on-a-chip
intestine model using a colon-specific extracellular matrix platform. Sci Rep. 2017;7(1):8837.
bioink. Adv Healthc Mater. 2022;11(2):2101768. doi: 10.1038/s41598-017-08879-x
doi: 10.1002/adhm.202101768
96. Goldstein Y, Spitz S, Turjeman K, et al. Breaking the third
84. Lampart FL, Iber D, Doumpas N. Organoids in high- wall: implementing 3D-printing techniques to expand the
throughput and high-content screenings. Front Chem Eng. complexity and abilities of multi-organ-on-a-chip devices.
2023;5:1120348. Micromachines. 2021;12(6):627.
doi: 10.3389/fceng.2023.1120348 doi: 10.3390/mi12060627
85. Szymański P, Markowicz M, Mikiciuk-Olasik E. Adaptation of 97. Díaz Lantada A, Pfleging W, Besser H, et al. Research on the
high-throughput screening in drug discovery—toxicological methods for the mass production of multi-scale organs-on-
screening tests. Int J Mol Sci. 2012;13(1):427-452. chips. Polymers. 2018;10(11):1238.
doi: 10.3390/ijms13010427 doi: 10.3390/polym10111238
86. Bajorath J. Integration of virtual and high-throughput 98. Picollet-D’hahan N, Zuchowska A, Lemeunier I, Le Gac S.
screening. Nat Rev Drug Discov. 2002;1(11):882-894. Multiorgan-on-a-chip: a systemic approach to model and
doi: 10.1038/nrd941 decipher inter-organ communication. Trends Biotechnol.
87. Probst C, Schneider S, Loskill P. High-throughput organ- 2021;39:788-810.
on-a-chip systems: current status and remaining challenges. doi: 10.1016/j.tibtech.2020.11.014
Curr Opin Biomed Eng. 2018;6:33-41. 99. Lee H, Cho D-W. One-step fabrication of an organ-on-
doi: 10.1016/j.cobme.2018.02.004 a-chip with spatial heterogeneity using a 3D bioprinting
88. Beaurivage C, Naumovska E, Chang YX, et al. Development technology. Lab Chip. 2016;16(14):2618-2625.
of a gut-on-a-chip model for high throughput disease doi: 10.1039/C6LC00450D
modeling and drug discovery. Int J Mol Sci. 2019;20(22):5661. 100. Zandrini T, Florczak S, Levato R, Ovsianikov A. Breaking
doi: 10.3390/ijms20225661 the resolution limits of 3D bioprinting: future opportunities
89. Azizgolshani H, Coppeta JR, Vedula EM, et al. High- and present challenges. Trends Biotechnol. 2023;41(5):
throughput organ-on-chip platform with integrated 604-614.
programmable fluid flow and real-time sensing for complex doi: 10.1016/j.tibtech.2022.10.009
tissue models in drug development workflows. Lab Chip. 101. Tian C-m, Yang M-f, Xu H-m, et al. Stem cell-derived
2021;21(8):1454-1474. intestinal organoids: a novel modality for IBD. Cell Death
doi: 10.1039/D1LC00067E Discov. 2023;9(1):255.
90. Mazrouei R, Velasco V, Esfandyarpour R. 3D-bioprinted doi: 10.1038/s41420-023-01556-1
all-inclusive bioanalytical platforms for cell studies. Sci Rep. 102. van Berlo D, Nguyen VVT, Gkouzioti V, Leineweber K,
2020;10(1):14669. Verhaar MC, van Balkom BWM. Stem cells, organoids,
doi: 10.1038/s41598-020-71452-6
and organ-on-a-chip models for personalized in vitro drug
91. Lind JU, Busbee TA, Valentine AD, et al. Instrumented testing. Curr Opin Toxicol. 2021;28:7-14.
cardiac microphysiological devices via multimaterial three- doi: 10.1016/j.cotox.2021.08.006

Volume 10 Issue 2 (2024) 180 doi: 10.36922/ijb.1704